NPCE Q3 2021 Earnings — NeuroPace, Inc. Revenue & Financial Results | Market Cap Arena

NPCENeuroPace, Inc.

$483M

Q3 2021 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$10M-19.0% YoY

Gross Profit

$8M72.6% margin

Operating Income

-$6M-60.4% margin

Net Income

-$8M-78.2% margin

EPS (Diluted)

$-0.34

QoQ Revenue Growth

-18.1%

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$5M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$141M

Total Liabilities

$60M

Stockholders' Equity

$82M

Cash & Equivalents

$27M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$10M	$13M	-19.0%
Gross Profit	$8M	$10M	-21.6%
Operating Income	-$6M	-$1M	-435.4%
Net Income	-$8M	-$4M	-95.9%